Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxine Taylor

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Antimicrobial Agents and Chemotherapy|October 5, 2016
Pharmacokinetic Interactions between Tafenoquine and Dihydroartemisinin-Piperaquine or Artemether-Lumefantrine in Healthy Adult SubjectsJustin A Green, Khadeeja Mohamed, Navin Goyal, et al.
BMJ (Clinical Research Ed.)|June 5, 2007
Long term results of compression therapy alone versus compression plus surgery in chronic venous ulceration (ESCHAR): randomised controlled trialManjit S Gohel, Jamie R Barwell, Maxine Taylor, et al.
Journal of Medicinal Chemistry|September 23, 2015
Navigating CYP1A Induction and Arylhydrocarbon Receptor Agonism in Drug Discovery. A Case History with S1P1 AgonistsSimon J Taylor, Emmanuel H Demont, James Gray, et al.
Malaria Journal|February 19, 2016
Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trialPamela L St Jean, Zhengyu Xue, Nick Carter, et al.
Lancet (London, England)|June 9, 2004
Comparison of surgery and compression with compression alone in chronic venous ulceration (ESCHAR study): randomised controlled trialJamie R Barwell, Colin E Davies, Jane Deacon, et al.
The Lancet. Child & Adolescent Health|December 6, 2021
Tafenoquine exposure assessment, safety, and relapse prevention efficacy in children with Plasmodium vivax malaria: open-label, single-arm, non-comparative, multicentre, pharmacokinetic bridging, phase 2 trialIván D Vélez, Tran T Hien, Justin A Green, et al.
The Lancet. Infectious Diseases|May 26, 2023
Tafenoquine co-administered with dihydroartemisinin-piperaquine for the radical cure of Plasmodium vivax malaria (INSPECTOR): a randomised, placebo-controlled, efficacy and safety studyInge Sutanto, Amin Soebandrio, Lenny L Ekawati, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Antimicrobial Agents and Chemotherapy|October 5, 2016
Pharmacokinetic Interactions between Tafenoquine and Dihydroartemisinin-Piperaquine or Artemether-Lumefantrine in Healthy Adult SubjectsJustin A Green, Khadeeja Mohamed, Navin Goyal, et al.
BMJ (Clinical Research Ed.)|June 5, 2007
Long term results of compression therapy alone versus compression plus surgery in chronic venous ulceration (ESCHAR): randomised controlled trialManjit S Gohel, Jamie R Barwell, Maxine Taylor, et al.
Journal of Medicinal Chemistry|September 23, 2015
Navigating CYP1A Induction and Arylhydrocarbon Receptor Agonism in Drug Discovery. A Case History with S1P1 AgonistsSimon J Taylor, Emmanuel H Demont, James Gray, et al.
Malaria Journal|February 19, 2016
Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trialPamela L St Jean, Zhengyu Xue, Nick Carter, et al.
Lancet (London, England)|June 9, 2004
Comparison of surgery and compression with compression alone in chronic venous ulceration (ESCHAR study): randomised controlled trialJamie R Barwell, Colin E Davies, Jane Deacon, et al.
The Lancet. Child & Adolescent Health|December 6, 2021
Tafenoquine exposure assessment, safety, and relapse prevention efficacy in children with Plasmodium vivax malaria: open-label, single-arm, non-comparative, multicentre, pharmacokinetic bridging, phase 2 trialIván D Vélez, Tran T Hien, Justin A Green, et al.
The Lancet. Infectious Diseases|May 26, 2023
Tafenoquine co-administered with dihydroartemisinin-piperaquine for the radical cure of Plasmodium vivax malaria (INSPECTOR): a randomised, placebo-controlled, efficacy and safety studyInge Sutanto, Amin Soebandrio, Lenny L Ekawati, et al.
Pageof 2